Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FISONS INVESTING $150 MIL. IN NEW MANUFACTURING FACILITY

Executive Summary

FISONS INVESTING $150 MIL. IN NEW MANUFACTURING FACILITY over the next four years in conjunction with a plan to improve efficiency at the company's Pharmaceutical Division. Fisons plc announced the capital spending project on Jan. 25. Construction of the new facility is expected to begin in late 1994 at Fisons' principal manufacturing site, Holmes Chapel in Cheshire, England. Fisons will continue to manufacture asthma inhalers and several other anti-allergy pharmaceuticals at Holmes Chapel; the new facility will be designed to produce non-chlorofluorocarbon products.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS023966

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel